Active, Not Recruiting
Infliximab for Treatment of Immune Checkpoint Inhibitor Colitis
NCT04305145
- Conditions
- Chemically-Induced Disorders, Colitis, Colonic Diseases, +24 more
- Locations
-
- Massachusetts General Hospital Cancer Center Boston, Massachusetts, United States
- Dana-Farber Cancer Institute Boston, Massachusetts, United States